HPAPIs and Oncology Products
Products
Information
Dr. Reddy's Custom Pharma Service offers a complete solution for highly potent and cytotoxic compounds from API development and manufacturing to development and commercial manufacturing of the finished product. We can support you with an exceptional breadth of capabilities for development and manufacture of nearly all classes of highly potent compounds. This breadth of capabilities covers classes of compounds, scale of operation, unit operations and geography of facilities. Within the class of cytotoxic products we have multiple high potency suites at our facilities in India. These include kilolab and various scales of commercial manufacturing with vessels up to 2500 liters. Containment is per most modern technologies, meeting limits of 0.2 μg/m3 over an 8 h exposure. We have 10 modules of varying size, each located within USFDA inspected manufacturing facilities and supplying products to all major markets worldwide. We also have the required laboratory experience and facility to develop processes for developmental APIs. Our FTO-7 site at Vizag in India is a state-of-the-art manufacturing facility for oncology products.
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
IndiaMexicoUnited Kingdom
All categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Contract ManufacturingServices
Main Categories
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)
